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Abstract: Kaposiform hemangioendothelioma (KHE) is a locally aggressive vascular tumor 
which usually occurs in infants. Clinically it appears as ill-deﬁ  ned red to purple indurated 
plaque. KHE is commonly associated with Kasabach-Merritt syndrome (KMS) and lymph-
angiomatosis. Microscopically, the tumor is composed of inﬁ  ltrating lobulated nodules with 
slitlike or crescentic vessels which are poorly canalized and lined by spindle shaped endothelial 
cells. We report a 36-year old female who developed a reddish tumor on the chest. Histological 
examination revealed a KHE, which was clinically not associated with thrombocytopenia or 
bleeding complications, but lymphangiomatosis at the right submandibular region. The associa-
tion of KHE in a female adult with lymphangioma rather than KMS in this case supports the 
hypothesis that such an association may represent a benign subform of this disease in an adult 
and excision seems to be curative.
Keywords: Kasabach-Merritt-Syndrom, Kaposiform hemangioendothelioma, lymphangi-
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Background
The term ‘hemangioendothelioma’ (HE) was introduced by Mallory in 1908 to include 
all ‘tumors arising from blood vessel endothelium’ (Mallory 1908). Notably, this name 
was established irrespective of the clinical behavior of the tumor. Forty years later, Stout 
and colleagues (1943) described the microscopic appearances of malignant tumors of 
blood vessels and linked the term HE to malignant behavior. This notion was put into 
perspective by Enzinger and Zhang (1988), who described HE as vascular tumors of 
intermediate, borderline, or low grade malignancy. Since then, this term has been used 
to designate various groups of vascular tumors; eg, kaposiform hemangioendothelioma 
(KHE) for a locally aggressive form. This rare vascular tumor, predominantly occurs 
in infancy and early childhood and is associated with lymphatic vessel proliferation as 
well as Kasabach-Merritt syndrome (KMS) (Kasabach and Merritt 1940; Niedt et al 
1989; Zukerberg et al 1993; Enjolras and Mulliken 1997; Sarkar et al 1997; Enjolras 
et al 2000). The ‘borderline’ malignant behavior of KHE is enriched by locally aggres-
sive growth (Tsang and Chan 1991), but distant metastatic spread is absent and could 
be cured by early and radical excision. Otherwise, KHE causes signiﬁ  cant morbidity 
and mortality compression and invasion of surrounding structures, disease-associated 
mortality may reach 12% (el Dessouky et al 1988).
Case presentation
In January 2005, a 36-year old patient perceived for the ﬁ  rst time a reddish 7 × 4 mm 
tumor on her right chest. She experienced neither itching nor bleeding from the lesion 
and no systemic or topical treatment had been applied. Her history as to personal Vascular Health and Risk Management 2008:4(1) 264
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or familial hemorrhage, thrombocytopenia or mucosal 
bleeding was inconspicuous. Thorough inspection of the 
entire integument revealed a few pigmented melanocytic 
lesions, which displayed no abnormalities upon clinical 
examination or epiluminescence microscopy. The only 
additional ﬁ  nding was a 2 × 2, 5 mm reddish macule with an 
indistinct border in the right submandibular region.
The tumor on the chest was excised since it was 
suspected to be an amelanotic melanoma. Histological 
examination revealed a dermally situated indistinctly 
demarcated mesenchymal process containing many 
capillary canaliculi lined by spindled epithelial cells. The 
tumor cells were characterized by slightly enlarged, oval-
shaped, and occasional prominent nuclei. A few mitotic 
ﬁ  gures were present within these cells. Dilated hyperplastic 
lymphatic channels (ie, lymphangiomatosis) were absent. 
Immunohistochemistry revealed a strong expression of 
CD31 (Figure 1A), CD34 (Figure 1B) and FLI1 – as nuclear 
marker for endothelial differentiation – whereas actin and 
HHV8 (Figure 1C) were not detectable. The patient was HIV 
negative. These ﬁ  ndings were consistent with the diagnosis 
of KHE and so it could be cured by a complete excision. 
Unfortunately a magnetic resonance imaging (MRI) was 
not done before excision to evaluate the extension of KHE 
because of the different tentative diagnosis.
A subsequently performed second excision ensured a 
safety margin of 5 mm. At the same time the macula at the 
right submandibular region was removed. Histologically, 
multiple dilated vessels in the upper dermis were vis-
ible. A few of the vessels contained erythrocytes in their 
lumina while the majority of the vessels only held lymph 
and stained positive for D2-40 (Figure 1D). The clinical 
follow up of the patient to date was without pathological 
ﬁ  ndings.
Figure 1 Immunohistology: immunohistochemical stainings for CD31 (A), CD34 (B), HHV8 (C), and D2-40 (D) of the chest tumor (immunoperoxidase, original magniﬁ  ca-
tion: A-C 40×, D 20×).
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Conclusion
Clinical and histological differential diagnosis of KHE in 
adults includes Kaposi sarcoma, amelanotic melanoma, 
spindle cell hemangioendothelioma, tufted angioma, 
cellular capillary hemangioma, and angiosarcoma (Fletcher 
et al 1991). Hence, the diagnosis critically depends on 
histopathological and immunohistochemical examination. 
Even if this tumor metastasizes only in rare cases (Lai et al 
1991; Bhutto et al 1995), it still has a systemic impact; ie, 
distant lymphatic abnormalities. In fact, the extent of these 
lymphatic abnormalities is more striking than previously 
noted (Zukerberg et al 1993). While the majority of KHE 
exhibit such changes in the immediate vicinity, lymphatic 
abnormalities in the lung and mediastinum have also 
been reported, particularly in young children (Enjolras 
and Mulliken 1997). Notably, one patient even died of 
this lymphatic proliferation (Lyons et al 2004). These 
lymphatic abnormalities seem to be evoked by systemic 
factors. Hypothetically, the tumor may produce lymphatic 
endothelial growth factors which incite proliferation of 
adjacent lymphatics; if the production of theses factors 
reaches sufﬁ  cient amounts, systemic effects on susceptible 
vessels may occur (Wigle et al 2002). The importance of 
tissue susceptibility is exempliﬁ  ed by the here reported 
ﬁ  ndings, ie, no lymphangiomatosis in the tumor stroma itself 
or its close vicinity, but in some distance.
Complete surgical excision is the most effective treat-
ment of small KHE lesions (Drolet et al 2001; George et al 
2002). However, tumor site or localization may prevent 
this treatment option. Moreover, an active intervention is 
required when KMS is present. To this end, therapy of KMS 
has proven to be a therapeutic challenge and may need mul-
timodality approach including steroids, cytotoxic agents and 
interferon α (Hu et al 1998).
In the presented case, neither the size of the tumor posed 
a problem for a surgical intervention nor did a coagulopathia 
require additional systemic measures. This report therefore 
supports the notions that (i) small KHE can be cured by 
complete excision and (ii) younger patients with KHE are 
more prone to KMS than adults (Shim 1968; Lyons et al 
2004). In this regard, Zukerberg and colleagues (1993) 
reported two cases of KHE associated with lymphangioma-
tosis which also did not show any signs of KMS and (iii) 
larger vascular tumors are more frequently associated with 
thrombocytopenia than small lesions. From this observation, 
it was concluded that lymphangiomatosis may actually be 
associated with noncoagulopathic tumors. One hypothesis 
is that KH begins as a lymphatic malformation onto which 
a vascular component is engrafted. This idea is supported 
by the occasional cases reported in the skin in which the 
lymphatic component overshadows the vascular component. 
A more elegant hypothesis is that KHE actually produces 
lymphatic endothelial growth factors, which incite prolifera-
tion of lymphatics. This hypothesis, although in concordance 
with our present observation, awaits conﬁ  rmation by large 
series of cases.
KHE has been believed to occur almost exclusively in 
infants and young children, however, an increasing number 
of cases in adults have been reported (Mentzel et al 1997; 
Mac-Moune et al 2001; Cooper et al 2002). Most of the adult 
patients showed KHE without an association with KMS but 
local or distant lymphangiomatosis.
Our present report of a 36-year-old patient suffering from 
KHE without KMS but distant lymphangiomatosis adds to 
this list. Hence, KHE in adults not associated with KMS 
but local or distant lymphangiomatosis may be regarded 
as a subform with favorable prognosis and can be cured by 
radical excision.
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